Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2011, Article ID 453619, 8 pages
http://dx.doi.org/10.1155/2011/453619
Research Article

Cellular Injury of Cardiomyocytes during Hepatocyte Growth Factor Gene Transfection with Ultrasound-Triggered Bubble Liposome Destruction

1Department of Cardiovascular Dynamics, Research Institute, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai,Suita, Osaka 565-8565, Japan
2Department of Nursing Science, Taisei Gakuin University, Sakai 587-8555, Japan
3Division of Molecular Regenerative Medicine, Department of Biochemistry and Molecular Biology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
4Division of Stem Cell Regulation Research, G6, Osaka University School of Medicine, Suita 565-0871, Japan
5Division of Hypertension, National Cerebral and Cardiovascular Center, Suita 565-8565, Japan

Received 6 August 2010; Accepted 31 October 2010

Academic Editor: Hasan Uludaǧ

Copyright © 2011 Kazuo Komamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Li, K. Tachibana, M. Kuroki, and M. Kuroki, “Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice—initial results,” Radiology, vol. 229, no. 2, pp. 423–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Tsunoda, O. Mazda, Y. Oda et al., “Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart,” Biochemical and Biophysical Research Communications, vol. 336, no. 1, pp. 118–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. B. Feril Jr. and T. Kondo, “Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound,” Journal of Radiation Research, vol. 45, no. 4, pp. 479–489, 2004. View at Publisher · View at Google Scholar
  4. W. J. Greenleaf, M. E. Bolander, G. Sarkar, M. B. Goldring, and J. F. Greenleaf, “Artificial cavitation nuclei significantly enhance acoustically induced cell transfection,” Ultrasound in Medicine and Biology, vol. 24, no. 4, pp. 587–595, 1998. View at Publisher · View at Google Scholar
  5. C. Teupe, S. Richter, B. Fisslthaler et al., “Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity,” Circulation, vol. 105, no. 9, pp. 1104–1109, 2002. View at Publisher · View at Google Scholar
  6. S. Chen, R. V. Shohet, R. Bekeredjian, P. Frenkel, and P. A. Grayburn, “Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction,” Journal of the American College of Cardiology, vol. 42, no. 2, pp. 301–308, 2003. View at Publisher · View at Google Scholar
  7. D.-P. Guo, X.-Y. Li, P. Sun et al., “Ultrasound-targeted microbubble destruction improves the low density lipoprotein receptor gene expression in HepG2 cells,” Biochemical and Biophysical Research Communications, vol. 343, no. 2, pp. 470–474, 2006. View at Publisher · View at Google Scholar
  8. R. Suzuki, T. Takizawa, Y. Negishi, N. Utoguchi, and K. Maruyama, “Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology,” International Journal of Pharmaceutics, vol. 354, no. 1-2, pp. 49–55, 2008. View at Publisher · View at Google Scholar
  9. H. L. Li, X. Z. Zheng, H. P. Wang, F. Li, Y. Wu, and L. F. Du, “Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo,” Gene Therapy, vol. 16, no. 9, pp. 1146–1153, 2009. View at Publisher · View at Google Scholar
  10. T. Horio, T. Nishikimi, F. Yoshihara, H. Matsuo, S. Takishita, and K. Kangawa, “Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes,” Hypertension, vol. 35, no. 1, part 1, pp. 19–24, 2000. View at Google Scholar · View at Scopus
  11. J.-S. Zheng, M. O. Boluyt, L. O'Neill, M. T. Crow, and E. G. Lakatta, “Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes,” Circulation Research, vol. 74, no. 6, pp. 1034–1041, 1994. View at Google Scholar
  12. M. Harada, H. Itoh, O. Nakagawa et al., “Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes,” Circulation, vol. 96, no. 10, pp. 3737–3744, 1997. View at Google Scholar
  13. K. Komamura, R. Tatsumi, J.-I. Miyazaki et al., “Treatment of dilated cardiomyopathy with electroporation of hepatocyte growth factor gene into skeletal muscle,” Hypertension, vol. 44, no. 3, pp. 365–371, 2004. View at Publisher · View at Google Scholar
  14. K. Matsumoto and T. Nakamura, “Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration,” Biochemical and Biophysical Research Communications, vol. 239, no. 3, pp. 639–644, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. B. B. Goldberg, JI. B. Liu, and F. Forsberg, “Ultrasound contrast agents: a review,” Ultrasound in Medicine and Biology, vol. 20, no. 4, pp. 319–333, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kato, G. Takemura, R. Maruyama et al., “Apoptosis, rather than oncosis, is the predominant mode of spontaneous death of isolated adult rat cardiac myocytes in culture,” Japanese Circulation Journal, vol. 65, no. 8, pp. 743–748, 2001. View at Publisher · View at Google Scholar
  17. O. J. Müller, H. A. Katus, and R. Bekeredjian, “Targeting the heart with gene therapy-optimized gene delivery methods,” Cardiovascular Research, vol. 73, no. 3, pp. 453–462, 2007. View at Publisher · View at Google Scholar
  18. C. A. Holladay, T. O'Brien, and A. Pandit, “Non-viral gene therapy for myocardial engineering,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 2, no. 3, pp. 232–248, 2010. View at Publisher · View at Google Scholar
  19. K. Matsumoto and T. Nakamura, “Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration,” Biochemical and Biophysical Research Communications, vol. 239, no. 3, pp. 639–644, 1997. View at Publisher · View at Google Scholar
  20. K. Matsumoto and T. Nakamura, “HGF: its organotrophic role and therapeutic potential,” CIBA Foundation Symposia, no. 212, pp. 198–211, 1997. View at Google Scholar
  21. N. Tomita, R. Morishita, J. Higaki, and T. Ogihara, “Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor,” Journal of Atherosclerosis and Thrombosis, vol. 7, no. 1, pp. 1–7, 2000. View at Google Scholar
  22. K. Komamura, J. Miyazaki, E. Imai, K. Matsumoto, T. Nakamura, and M. Hori, “Hepatocyte growth factor gene therapy for hypertension,” Methods in Molecular Biology, vol. 423, pp. 393–404, 2008. View at Google Scholar
  23. K.-I. Kosai, K. Matsumoto, S. Nagata, Y. Tsujimoto, and T. Nakamura, “Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor,” Biochemical and Biophysical Research Communications, vol. 244, no. 3, pp. 683–690, 1998. View at Publisher · View at Google Scholar
  24. T. Ueki, Y. Kaneda, H. Tsutsui et al., “Hepatocyte growth factor gene therapy of liver cirrhosis in rats,” Nature Medicine, vol. 5, no. 2, pp. 226–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mizuno, K. Matsumoto, and T. Nakamura, “HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease,” Frontiers in Bioscience, vol. 13, pp. 7072–7086, 2008. View at Google Scholar
  26. K. Matsumoto and T. Nakamura, “Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases,” Kidney International, vol. 59, no. 6, pp. 2023–2038, 2001. View at Publisher · View at Google Scholar
  27. K. Tachibana, T. Uchida, K. Ogawa, N. Yamashita, and K. Tamura, “Induction of cell-membrane porosity by ultrasound,” The Lancet, vol. 353, no. 9162, p. 1409, 1999. View at Google Scholar
  28. S. Mehier-Humbert, T. Bettinger, F. Yan, and R. H. Guy, “Plasma membrane poration induced by ultrasound exposure: implication for drug delivery,” Journal of Controlled Release, vol. 104, no. 1, pp. 213–222, 2005. View at Publisher · View at Google Scholar
  29. F. Yang, N. Gu, D. Chen et al., “Experimental study on cell self-sealing during sonoporation,” Journal of Controlled Release, vol. 131, no. 3, pp. 205–210, 2008. View at Publisher · View at Google Scholar
  30. D. M. Skyba, R. J. Price, A. Z. Linka, T. C. Skalak, and S. Kaul, “Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue,” Circulation, vol. 98, no. 4, pp. 290–293, 1998. View at Google Scholar · View at Scopus
  31. J. Song, J. C. Chappell, M. Qi, E. J. VanGieson, S. Kaul, and R. J. Price, “Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle,” Journal of the American College of Cardiology, vol. 39, no. 4, pp. 726–731, 2002. View at Publisher · View at Google Scholar
  32. S. Hernot and A. L. Klibanov, “Microbubbles in ultrasound-triggered drug and gene delivery,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1153–1166, 2008. View at Publisher · View at Google Scholar
  33. M. R. Böhmer, C. H. T. Chlon, B. I. Raju, C. T. Chin, T. Shevchenko, and A. L. Klibanov, “Focused ultrasound and microbubbles for enhanced extravasation,” Journal of Controlled Release, vol. 148, no. 1, pp. 18–24, 2010. View at Publisher · View at Google Scholar
  34. I. Rosenthal, J. Z. Sostaric, and P. Riesz, “Sonodynamic therapya review of the synergistic effects of drugs and ultrasound,” Ultrasonics Sonochemistry, vol. 11, no. 6, pp. 349–363, 2004. View at Publisher · View at Google Scholar
  35. J. M. Tsutsui, F. Xie, and R. T. Porter, “The use of microbubbles to target drug delivery,” Cardiovascular Ultrasound, vol. 2, article 23, 2004. View at Publisher · View at Google Scholar
  36. C. M. H. Newman and T. Bettinger, “Gene therapy progress and prospects: ultrasound for gene transfer,” Gene Therapy, vol. 14, no. 6, pp. 465–475, 2007. View at Publisher · View at Google Scholar
  37. C. R. Mayer and R. Bekeredjian, “Ultrasonic gene and drug delivery to the cardiovascular system,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1177–1192, 2008. View at Publisher · View at Google Scholar
  38. S. Hernot and A. L. Klibanov, “Microbubbles in ultrasound-triggered drug and gene delivery,” Advanced Drug Delivery Reviews, vol. 60, no. 10, pp. 1153–1166, 2008. View at Publisher · View at Google Scholar
  39. S. Tinkov, R. Bekeredjian, G. Winter, and C. Coester, “Microbubbles as ultrasound triggered drug carriers,” Journal of Pharmaceutical Sciences, vol. 98, no. 6, pp. 1935–1961, 2009. View at Publisher · View at Google Scholar
  40. C.-Y. Lin, T.-M. Liu, C.-Y. Chen et al., “Quantitative and qualitative investigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors,” Journal of Controlled Release, vol. 146, no. 3, pp. 291–298, 2010. View at Publisher · View at Google Scholar